Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors
GenVivo, Inc.
GenVivo, Inc.
National Institutes of Health Clinical Center (CC)
The Methodist Hospital Research Institute
City of Hope Medical Center
National Taiwan University Hospital
Rznomics, Inc.
Sun Yat-sen University
Viracta Therapeutics, Inc.
Stanford University
University of Minnesota
National Institute of Cancerología
Karolinska Institutet
National Institutes of Health Clinical Center (CC)
University of California, San Diego
Chang Gung Memorial Hospital
Medical University of Vienna
M.D. Anderson Cancer Center
HemaQuest Pharmaceuticals Inc.
HemaQuest Pharmaceuticals Inc.